Loxam Teri 的 Form 4 申報
Vaxcyte, Inc.（PCVX），2025/1/17 申報
- 申報編號
- 0001649094-25-000006
- 申報時間
- 2025/1/17
- 交易日
- 2025/1/15
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 9 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $53.2 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Loxam TeriCIK 0001829111 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/1/15 | Common Stock | M行使選擇權取得 | +6,250 | $22.70 | +$141,875 | 13,425 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −146 | $80.46F2 | −$11,747.16 | 13,279 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −215 | $81.53F3 | −$17,528.95 | 13,064 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −1,136 | $82.89F4 | −$94,163.04 | 11,928 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −1,202 | $83.93F5 | −$100,883.86 | 10,726 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −1,043 | $85.29F6 | −$88,957.47 | 9,683 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −966 | $86.26F7 | −$83,327.16 | 8,717 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −1,013 | $87.38F8 | −$88,515.94 | 7,704 | 直接 | |
| 2025/1/15 | Common Stock | S賣出處分 | −529 | $88.54F9 | −$46,837.66 | 7,175 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/1/15 | Common Stock | M行使選擇權處分 | −6,250 | $0.00 | $0 | 6,250 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported is a weighted-average price. The shares were sold at prices ranging from $80.32 to $80.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported is a weighted-average price. The shares were sold at prices ranging from $81.36 to $81.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported is a weighted-average price. The shares were sold at prices ranging from $82.455 to $83.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
The price reported is a weighted-average price. The shares were sold at prices ranging from $83.51 to $84.37. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The price reported is a weighted-average price. The shares were sold at prices ranging from $84.83 to $85.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The price reported is a weighted-average price. The shares were sold at prices ranging from $85.89 to $86.59. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The price reported is a weighted-average price. The shares were sold at prices ranging from $86.89 to $87.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The price reported is a weighted-average price. The shares were sold at prices ranging from $87.915 to $88.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。